Mentor v. American Medical Systems
This article was originally published in The Gray Sheet
Executive Summary
Urology firms settle alleged infringement of Mentor's '211 trans-obturator patent, related to the firm's ObTape and AMS' Monarc subfascial hammocks for stress urinary incontinence in women. The deal includes a one-time payment by AMS of $2.5 mil. to Mentor and a non-exclusive cross-licensing agreement. Related lawsuits will be dismissed (1"The Gray Sheet" March 31, 2004, p. 13)...
You may also be interested in...
Litigation In Brief
J&J/Medtronic stent litigation: Supreme Court declines to review ruling awarding Johnson & Johnson/Cordis $271 mil. for infringement of stent patents, including those related to its Palmaz-Schatz('762), denying a writ of certiorari in the case. The U.S. Court of Appeals for the Federal Circuit had denied a rehearing in September 2003 after siding with J&J last August and remanded the case back to its original Wilmington, Del. district court (1"The Gray Sheet" Oct. 6, 2003, In Brief). Medtronic notes that the stents at issue are obsolete...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.